Evidence-based follow-up in non-small cell lung cancer

ConclusionCurrent evidence from the literature supports a more intense routine follow-up in NSCLC during the first 2 years after treatment, followed by less frequent regular visits life-long.

http://link.springer.com/10.1007/s12254-019-00566-z

Source: Memo - Magazine of European Medical Oncology - January 22, 2020 Category: Cancer & Oncology Source Type: research

More News: Cancer | Cancer & Oncology | Clinical Trials | Lung Cancer | Non-Small Cell Lung Cancer